Creative Biostructure today announced the establishment of multifunctional liposome platforms to support all stages of drug research and development. SHIRLEY, NY, UNITED STATES, September 26, 2024 /EINPresswire.com/ -- Creative Biostructure, a leading provider of structural biology and biotechnology services, today announced the establishment of multifunctional liposome platforms to support all stages of drug research and development, underscoring the company's commitment to advancing drug delivery systems and enabling researchers to bring novel therapies to market more efficiently.
Liposomes, vesicles composed of one or more phospholipid bilayers, have emerged as a powerful tool in drug delivery due to their ability to stabilize therapeutic compounds, improve biodistribution, prolong circulation time, and reduce systemic toxicity. Creative Biostructure's liposome platforms harness the flexibility of liposome technology, offering customizable formulations to address diverse delivery requirements across various applications.
"We recognized the immense potential of liposomes to transform drug delivery and are dedicated to providing researchers with the most advanced platforms to unlock this potential," said Joanna, the chief marketing staff at Creative Biostructure. "Our expertise in liposome design and manufacturing enables us to create tailored solutions that overcome the complex challenges of drug delivery and enhance treatment outcomes."
Beyond drug delivery, Creative Biostructure's liposome platforms also support applications in cosmetics, where liposomes act as moisturizers and nutrient carriers, and in the food industry, where liposomes encapsulate and deliver nutritional factors and functional ingredients.
Creative Biostructure’s systems for producing liposomes are customized to fit the needs of many applications by customizing the preparation and design of liposomes. Services include:
Non-PEGylated Liposome (NPL) Production
Multivesicular Liposome Production
Lysolipid Thermally Sensitive Liposomes
Photo-Activated Liposome Production
Transferosome Production
Cosmetic-Grade Liposome Production
Pharmacosome Production
Cyclodextrin-based Liposome Production
Nano-Liposomes Formulation Production
Food-Grade Liposome Production
...
"By providing access to these cutting-edge liposome platforms, we aim to empower researchers to push the boundaries of drug delivery and unlock new possibilities for the treatment of a wide range of diseases," said Joanna. "We are committed to supporting our partners at every stage of the development journey, from formulation and characterization to scale-up and manufacturing."
To learn more about Creative Biostructure's liposome platforms, please visit https://www.creative-biostructure.com/liposome-production-546.htm,
About Creative Biostructure Creative Biostructure is a leading provider of structural biology and biotechnology services, offering a range of platforms and technologies to support drug discovery and development. With expertise spanning protein expression and purification to liposome design and manufacturing, Creative Biostructure is dedicated to empowering researchers to advance novel therapies and improve patient outcomes.
Joanna BowieCreative Biostructureemail us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
You just read:
News Provided By
Joanna Bowie, Creative Biostructure
September 26, 2024, 17:00 GMT
EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above. Originally published at https://www.einpresswire.com/article/746677980/creative-biostructure-bolsters-drug-development-with-advanced-liposome-platforms